latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
The Medical News
Sat, 04/17/10 - 12:49 pm
Forbes/Reuters
Wed, 08/19/09 - 7:29 am
tags: anti-fungal, BioAlliance, FDA, Loramyc, Par Pharmaceutical, Strativa
Last 30 twitter posts
-
Avoid the risks that come with high CRO turnover rates. Go for the best partnerships options. Talk with BioAlliance t.co/k74jMixd7J
-
Build the social mktg / bus dev model that works for you. BioAlliance Stategies t.co/en4qEVQoDA t.co/EZz0ApcNoZ
-
BioAlliance Pharma obtient le feu vert de la FDA pour l'herpès, Innovateurs t.co/vmRN7tdNqk
-
Increase market presence. Connect with high-value prospects. Reduce mktg/bd costs. BioAlliance Strategies t.co/EQ94E3any0
-
Avoid sky-high CRO turnover rates. Understand your partnerships options Talk with BioAlliance t.co/YvPqI6ixqn t.co/1pTu4Y6Gf4
-
Build the social mktg / bus dev model that works for you. BioAlliance Stategies t.co/niHXptiR9k t.co/UXKjmh4hwr
-
Build the social mktg / bus dev model that works for you. BioAlliance Stategies t.co/YvPqI6ixqn t.co/FCrpVab4kD